NPCE NeuroPace Inc
company
SEC Filings & Insider Trading Activity 2026

CIK: 1528287
Health Care
Surgical & Medical Instruments & Apparatus 33 filings
Russell 2000

Latest NeuroPace Inc (NPCE) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on March 3, 2026, a 10-Q quarterly report filed on May 12, 2026, an 8-K current report filed on July 28, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for NeuroPace Inc (NPCE) (SEC CIK 1528287), with AI-powered section-by-section summaries updated daily.

10-Q: 16
SC 13G: 7
10-K: 5
8-K: 4
SC 13D: 1

Latest 2026 SEC Filing Dates

10-K Annual Report
Mar 3, 2026
10-Q Quarterly Report
May 12, 2026
8-K Current Report
Jul 28, 2026

Go deeper on NeuroPace Inc

Ask AI about NPCE filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.

Track institutional money. See which funds are building or cutting NPCE positions, quarter over quarter.

Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on NPCE.

Recent 8-K Filings
Current Reports

AI-powered analysis of NeuroPace Inc (NPCE) 8-K current reports disclosing material events.

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling DatePeriodAnalysisSEC
8-K
Jul 28, 2026---
8-K
Jun 8, 2026--
10-Q
May 12, 2026Mar 31, 2026-
8-K
May 12, 2026--
8-K
Mar 3, 2026-Analysis-
10-K
Mar 3, 2026Dec 31, 2025-
10-Q
Nov 4, 2025Sep 30, 2025-
10-Q
Aug 12, 2025Jun 30, 2025-
10-Q
May 13, 2025Mar 31, 2025-
10-K
Mar 4, 2025Dec 31, 2024-
10-Q
Nov 12, 2024Sep 30, 2024-
10-Q
Aug 13, 2024Jun 30, 2024-
10-Q
May 8, 2024Mar 31, 2024-
10-K
Mar 5, 2024Dec 31, 2023-
10-Q
Nov 6, 2023Sep 30, 2023-
10-Q
Aug 8, 2023Jun 30, 2023-
10-Q
May 4, 2023Mar 31, 2023-
10-K
Mar 2, 2023Dec 31, 2022-
SC 13G
Feb 10, 2023--
SC 13G
Feb 9, 2023--
SC 13D
Nov 21, 2022--
10-Q
Nov 8, 2022Sep 30, 2022-
SC 13G
Oct 7, 2022--
10-Q
Aug 11, 2022Jun 30, 2022-
10-Q
May 12, 2022Mar 31, 2022-

13F Fund Holdings: Quarterly Trend

Latest: Q1 2026

Aggregate NPCE share value held by 13F filers tracked by SignalX, by quarter.

Position changes: Q4 2025Q1 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 111 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.

Frequently Asked Questions

What are the latest NPCE SEC filings in 2026?

NeuroPace Inc (NPCE) has filed a 10-K annual report on March 3, 2026, a 10-Q quarterly report on May 12, 2026, an 8-K current report on July 28, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did NPCE file its most recent 10-K annual report?

NeuroPace Inc (NPCE) filed its most recent 10-K annual report on March 3, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view NPCE 10-Q quarterly reports?

NeuroPace Inc (NPCE)'s most recent 10-Q quarterly report was filed on May 12, 2026. SignalX displays every NPCE 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has NPCE filed recently?

NeuroPace Inc (NPCE)'s most recent 8-K was filed on July 28, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find NPCE insider trading activity (Form 4)?

SignalX aggregates every NPCE Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does NPCE file with the SEC?

NeuroPace Inc (NPCE) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new NPCE filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for NeuroPace Inc (NPCE).

What is NPCE's SEC CIK number?

NeuroPace Inc (NPCE)'s SEC CIK (Central Index Key) number is 1528287. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1528287 to look up all NPCE filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Stay on top of NeuroPace Inc SEC filings

Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 33+ filings.